1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow moxonidine: new trials by email Literature Review of moxonidine trials Research Report on moxonidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sympathetic Mechanisms in Obesity-Crossover Design Amlodipine, Moxonidine, Placebo - Obesity, Hypertension | Phase 1 / Phase 2 | Recruiting | Vanderbilt University Medical Center | 12 | 2022-05-20 | 2026-02-27 |
| Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity Moxonidine 0.2 MG, Amlodipine 5 MG - Obesity-Associated Insulin Resistance | Phase 1 | Terminated | Italo Biaggioni | 10 | 2021-02-23 | 2025-09-05 |
Hypertension (1) · Obesity (1)
Italo Biaggioni (1) · Vanderbilt University Medical Center (1)
United States (2)
R01HL149386 (1)